Prospective Observation of Cardiac Safety With Proteasome Inhibition

A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure

NCT01357850 ·Status: COMPLETED ·Phase: PHASE2

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

NCT05305911 ·Status: RECRUITING ·Phase: PHASE2

Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure

NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158

NCT00849108 ·Status: COMPLETED ·Phase: PHASE2

Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

NCT02750319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698

NCT03044353 ·Status: TERMINATED ·Phase: PHASE2

Study of AG10 in Amyloid Cardiomyopathy

NCT03458130 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

NCT01877915 ·Status: COMPLETED ·Phase: PHASE3

CD-NP in Subjects With Stable Chronic Heart Failure

NCT00620308 ·Status: COMPLETED ·Phase: PHASE1

Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure

NCT06158711 ·Status: NOT_YET_RECRUITING

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

NCT01067859 ·Status: TERMINATED ·Phase: PHASE2

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation

NCT03087487 ·Status: COMPLETED

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

NCT00050076 ·Status: COMPLETED ·Phase: PHASE2

Desflurane-induced Myocardial Protection

NCT02019797 ·Status: UNKNOWN ·Phase: PHASE4

Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

NCT04195997 ·Status: UNKNOWN ·Phase: PHASE4

Effect Of GW501516X On How The Heart Obtains And Uses Energy

NCT00318617 ·Status: TERMINATED

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT06560762 ·Status: RECRUITING ·Phase: PHASE1

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

NCT05233163 ·Status: COMPLETED ·Phase: PHASE4

A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

NCT00742508 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

NCT01055912 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn How the Study Treatment BAY1753011 Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body When Given Once as Tablet in Male and Female Participants With Reduced Kidney Function Compared to Matched Participants With Normal Kidney Function

NCT05599997 ·Status: COMPLETED ·Phase: PHASE1

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

NCT05598333 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

NCT05111769 ·Status: UNKNOWN ·Phase: NA

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

NCT03098979 ·Status: COMPLETED ·Phase: PHASE2

Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure

NCT06137430 ·Status: NOT_YET_RECRUITING